ASKA Pharmaceutical Co Ltd (4514.T)
16 Jul 2019
Latest Key Developments (Source: Significant Developments)
July 6 (Reuters) - ASKA Pharmaceutical Co Ltd <4514.T>:Says it voluntarily recalls hypertension treatment drug valsartan 20mg・40mg・80mg・160mgAA from July 5 . Full Article
Takeda Pharmaceutical and ASKA Pharmaceutical enter into licensing agreement for relugolix in women's health indications
May 31 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>:Says it and ASKA Pharmaceutical Co Ltd <<<4514.T>>> announced today that they entered inter a licensing agreement to grant ASKA exclusive commercialization right for uterine fibroids and exclusive development and commercialization rights for endometriosis for Japan to maximize the product value of Takeda-owned relugolix.Based on this agreement, Takeda will receive upfront payment for granting the exclusive commercialization right for uterine fibroids and the exclusive development and commercialization rights for endometriosis in Japan as well as holding the right to receive royalties on sales. Full Article
April 16 (Reuters) - ASKA Pharmaceutical Co Ltd <4514.T>:Says it will set up a pharmaceutical JV with Omnicare Drugs India Private Limited, in India, in May .Says the JV will be capitalized at $12.5 million .Says it will hold 30 percent stake in the JV . Full Article
TOKYO, Feb 5 Japan's Nikkei index surrendered modest gains to end lower on Tuesday, snapping a three-day rally as the market digested a slew of corporate earnings.